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448Objective: The objective was to study the clinical course of children requiring continuous renal replacement
therapy (CRRT) after cardiac surgery and to analyze the factors associated with mortality.
Methods:A prospective observational study was performed that included all children requiring CRRTafter car-
diac surgery, comparing these patients with other critically ill children requiring CRRT. Univariate and multi-
variate analyses were performed to determine the influence of each factor on mortality.
Results: Eighty-one (4.9%) of 1650 children undergoing cardiac surgery required CRRT; 65 of them (80.2%)
presented multiorgan failure. Children starting CRRT after cardiac surgery had lower mean arterial pressure
and lower urea and creatinine levels, and were more likely to require mechanical ventilation than other chil-
dren on CRRT. The incidence of complications was similar. Cardiac surgery increased the probability of re-
quiring CRRT for more than 14 days. Mortality was 43% in children receiving CRRT after cardiac surgery and
29% in other children (P ¼ .05). Factors associated with mortality in the univariate analysis were age less than
12 months, weight less than 10 kg, higher Pediatric Risk of Mortality Score, hypotension, lower urea and cre-
atinine on starting CRRT, and use of hemofiltration. In the multivariate analysis, the only factor associated
with mortality was hypotension on starting CRRT (hazard ratio, 4.01; 95% confidence interval, 1.2-13.4;
P ¼ .024).
Conclusions: Although only a small percentage of children undergoing cardiac surgery required CRRT, mor-
tality in these patients was high. Hypotension at the time of starting the technique was the only factor associated
with a higher mortality. (J Thorac Cardiovasc Surg 2013;146:448-54)Advances in the surgical treatment of children with congen-
ital heart disease have led to an increase in survival. How-
ever, children undergoing complex cardiac surgery and
those in whom multiorgan failure develops present a higher
incidence of acute kidney injury (AKI).1 Patients post-
cardiac surgery are prone to develop AKI because of low
cardiac output, hemolysis, and septic complications.2 The
incidence of AKI after cardiac surgery in adults was esti-
mated at 2.7% to 30%, depending on the definition
used,3-6 and the presence of AKI was associated with
a significant increase in mortality.6 Approximately 1% to
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The Journal of Thoracic and Cardiovascular Surgand the need for dialysis is associated with a high mortality,
a more complicated in-hospital course, and a higher risk of
infectious complications.5,6
In children, the reported incidence of AKI requiring renal
replacement therapy after cardiac surgery with cardiopul-
monary bypass varies from 1% to 17%, depending on
the complexity of the surgery.2,7-10 Continuous renal
replacement therapy (CRRT) offers continuous, steady
fluid removal and uremic toxin clearance. The intensity of
treatment can be titrated to treat or prevent volume
overload. Myocardial depressant factors can be removed,
myocardial performance can be improved, and nutrition
can be optimized.3
There is little information on the clinical course of
children requiring CRRT after cardiac surgery,2 and
there are no studies that have determined the factors as-
sociated with survival. The objective of the present study
was to analyze the clinical course of children on CRRT
after cardiac surgery and the factors associated with
survival.PATIENTS AND METHODS
A prospective, observational study was performed that included all crit-
ically ill children who were admitted to the pediatric intensive care unit
(PICU) between January 1, 1996, and June 1, 2009, and treated with
CRRT.11 The study was approved by the local institutional review board.ery c August 2013
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ACT ¼ activated clotting time
AKI ¼ acute kidney injury
CI ¼ confidence interval
CRRT ¼ continuous renal replacement therapy
HR ¼ hazard ratio
PELOD ¼ Pediatric Logistic Organ Dysfunction
PICU ¼ pediatric intensive care unit
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MThis secondary study has analyzed the subgroup of children undergoing
cardiac surgery. During the study period, CRRTwas required by 174 crit-
ically ill children. A total of 81 patients with CRRT (55 boys [68%] and 26
girls [32%], with a mean [standard deviation] age of 50 [64] months) were
in the postoperative period of cardiac surgery, and these were the patients
included in the study. There were 43 patients (53%) aged less than 1 year,
and 26% of patients weighed less than 5 kg. Three different CRRT moni-
tors were used to perform treatment: BSM321C, Prisma, and Prismaflex
(Hospal, Madrid, Spain). Catheters between 5F and 11F were used depend-
ing on the age and weight of the child.
Polyacrylonitrile AN69 or polysulfone hollow-fiber hemofilters were
used depending on the patient’s body surface area and the pump used.
M10R (Hospal, Lyon, France) 0.04 m2 or FH22R (Renaflow; Minntech,
Minneapolis, Minn) 0.15 m2 filters were used in children weighing less
than 5 kg; M60R (Hospal, Lyon, France) 0.6 m2 or HF400R (LinC Medical
Systems, Leicestershire, UK) 0.3 m2 filters (Renaflow) were used in pa-
tients weighing 5 to 35 kg; andM100R (Hospal, Lyon, France) 0.9m2 filters
were used in children weighing more than 35 kg.
Commercially prepared, bicarbonate-buffered hemofiltration replace-
ment fluid (Clearflex; Bieffe Medital, Madrid, Spain) was infused prefilter.
Bicarbonate-buffered dialysis fluid (Dialisan CVVHD; Hospal, Madrid,
Spain) was used in patients on continuous venovenous hemodiafiltration.
The intensivist decided when to initiate CRRT regardless of the time of
day, if therewas anuria or oliguria (<0.5 mL/kg/h), and especially when the
fluid balance was positive with high doses of diuretics (eg, furosemide 1
mg/kg/h) for 6 to 12 hours.
Continuous venovenous hemofiltration was used in 30% of patients,
and continuous venovenous hemodiafiltration was used in 70% of patients;
the decision on whether to use hemofiltration or hemodiafiltration was the
responsibility of the treating physician and was based on the patient’s need
for solute clearance.
A heparin bolus of 20 to 50 IU/kg was administered at the time of start-
ing CRRT; the dose was determined according to the baseline activated
clotting time (ACT): Patients with a normal baseline ACT received a bolus
of 50 IU/kg, which was reduced to 20 IU/kg in patients with a baseline ACT
more than 200 seconds. This was followed by a continuous heparin infusion
via the pre-blood pump port, aiming to maintain a postfilter ACT between
150 and 200 seconds.
A prospective record of the following data was created for all patients at
the time of starting CRRT: age, weight, sex, diagnosis, severity scores
(Pediatric Index of Mortality [PIM] II,12 Pediatric Risk of Mortality Score
[PRISM] II,13 and Pediatric Logistic Organ Dysfunction [PELOD]14),
number of organs affected according to the International Pediatric Sepsis
Consensus Conference,15 blood pressure, vasoactive drug requirements,
doses of dopamine and adrenaline, vasoactive inotropic score,16 lactic
acid levels, pH and base excess, creatinine, urea, alanine aminotransferase,
bilirubin, and type of CRRT monitor used. Hypotension was defined as
a mean arterial pressure more than 2 standard deviations below normalThe Journal of Thoracic and Cafor the patient’s age. Cardiac output was not measured in most of the pa-
tients. Low cardiac output was defined by clinical criteria (poor peripheral
perfusion, blood pressure, heart rate) plus echocardiography and analytic
methods (venous oxygen saturation, lactic acid). During therapy, a daily re-
cord was kept of the use of hemodiafiltration or hemofiltration, maximum
dose of heparin, ultrafiltration rate, life of each filter, CRRT-related compli-
cations, and mortality during admission to the PICU.
Statistical analysis was performed using SPSS version 15.0 (SPSS Inc,
Chicago, Ill). The chi-square, Fisher exact, and Mann–Whitney tests were
used to compare the qualitative and quantitative variables. Univariate and
multivariate Cox regression analyses were performed to analyze the influ-
ence of each factor on mortality. In the multivariate model, we included the
baseline factors that were associated with mortality by univariate regres-
sion analysis.RESULTS
A total of 1650 patients in the postoperative period of car-
diac surgery were admitted to the unit between January
1996 and April 2009, 94 of whom (5.6%) received heart
transplants. CRRT was required in 81 patients (4.9%), in-
cluding 18 who had undergone heart transplantation
(19%). The most common diagnoses and operations per-
formed and the risk adjustment for surgery for congenital
heart disease17 are listed in Table 1. Thirteen patients re-
ceived extracorporeal membrane oxygenation assistance.
The most common indications for CRRTwere AKI with hy-
pervolemia (37%), isolated AKI (36%), and hypervolemia
refractory to diuretic treatment (25%). The characteristics
of the CRRT are summarized in Table 2. Venous access
was most commonly achieved by cannulation of the femoral
vein. In 13 patients, the pumpwas inserted into the extracor-
poreal membrane oxygenation circuit.18
The characteristics of the patients, their clinical severity,
and the treatment they were receiving at the time of starting
CRRT are detailed in Table 3, which also shows a compari-
son of the characteristics with the other children treated by
CRRT. After cardiac surgery, patients were more likely to
require CRRT than other patients (4.9% vs 1.6%). Of the
children requiring CRRT after cardiac surgery, 38% were
aged less than 6 months. There was no difference in age
in comparison with other patients on CRRT, although
a larger percentage of patients in the post-cardiac surgery
group were aged less than 12 months (53% vs 35%;
P ¼ .02). Forty-seven children (58%) weighed less than
10 kg, and 15 children (26%) weighed less than 5 kg. There
were no differences in the mortality calculated according to
the PRISM, PIM, or PELOD scores in children on CRRTaf-
ter cardiac surgery and in other patients on CRRT. Organ
failure of more than 3 organs was detected in 80.2% of pa-
tients requiring CRRT after cardiac surgery.
The mean arterial pressure in children with heart disease
was significantly lower than in the other patients, and 95%
required vasoactive drugs, with a higher inotropic index
than the other patients. In addition, more of these patients
were on mechanical ventilation at the time of starting
CRRT. The mean urea and creatinine levels at the time ofrdiovascular Surgery c Volume 146, Number 2 449
TABLE 1. Surgical procedures in the patients with heart disease
Surgical procedure No. %
Heart transplant 18 22.2
Surgical repair of ventricular septal defect 5 6.2
Surgical repair of complete atrioventricular canal defect 6 7.4
Repair of tetralogy of Fallot 10 12.3
Norwood’s reconstruction 2 2.5
Bidirectional Glenn procedure 9 11.1
Fontan procedure 12 14.8
Critical aortic stenosis; Ross-Konno operation 2 2.5
Aortic arch reconstruction 2 2.5
Mitral valvuloplasty 7 8.6
Transposition of the great arteries; arterial switch operation 5 6.2
Pulmonary atresia with major aortopulmonary collateral
arteries; unifocalization surgery
3 3.7
RACHS classification
RACHS 2 24 38.1
RACHS 3 32 50.8
RACHS 4 3 4.8
RACHS 5 2 3.1
RACHS 6 2 3.1
RACHS, Risk Adjustment for Congenital Heart Surgery.
TABLE 2. Characteristics of continuous renal replacement therapy in
children who underwent cardiac surgery
Characteristic No. (%)
Vascular access
Femoral vein 54 (67%)
Jugular vein 13 (16%)
Subclavian vein 6 (7%)
Inserted into the ECMO circuit 3 (4%)
Other access 5 (6%)
Type of CRRT pump
Prisma (Hospal, Madrid, Spain) 63 (77%)
BSM321C (Hospal) 15 (19%)
Prismaflex (Hospal) 3 (4%)
Catheter
5F 8 (10%)
6.5F 42 (52%)
7-9F 13 (16%)
10-11F 10 (12%)
Various 5 (6%)
Filter surface area
0.04 m2 25 (31%)
0.15 m2 7 (8%)
0.6 m2 28 (35%)
0.9 m2 13 (16%)
Various 8 (10%)
Technique
Hemofiltration 24 (30%)
Hemodiafiltration 57 (70%)
Flow rates Mean
Blood flow (mL/kg/min) 5.5
Replacement fluid flow (mL/h) 289
Dialysis fluid flow (mL/h) 464
Total effluent flow (mL/kg/h) 53
Total duration of treatment (h) 271
No. of filters/patient 6
Mean filter life (h) 50
ECMO, Extracorporeal membrane oxygenation;CRRT, continuous renal replacement
therapy.
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Mstarting therapy were lower. The mean duration of the filters
was 50 hours, which was significantly longer than in the
other patients, although the maximum dose of heparin
was slightly higher (Table 3).
Complications developed in 65% of the children on
CRRTafter cardiac surgery. The incidence of complications
and a comparison with the other patients are shown in
Table 4. Hypokalemia was the only complication with a sig-
nificantly higher incidence in patients on CRRT after
cardiac surgery than in other patients.
Continuation of CRRT for more than 14 days was re-
quired by 22 patients (27%) after cardiac surgery and for
more than 21 days by 15 patients (18.5%). In the logistic
regression study, the diagnosis of heart disease increased
the probability of requiring prolonged CRRT (hazard ratio
[HR], 1.491; 95% confidence interval [CI], 1.299-2.840;
P ¼ .001).
Table 5 compares the characteristics of the patients aged
less than 1 year postcardiac surgery who required CRRT
with the characteristics of the older patients. Initial urea
and creatinine, and duration of filters and hemodiafiltration
were lower and hypophosphatemia was higher in patients
aged less than 12 months. Mortality of younger patients
was higher, but the difference was not statistically
significant.
Themortality of patients undergoing cardiac surgery who
required CRRTwas higher than that of patients who did not
need require CRRT (43% vs 4%; P<.001). Mortality also
was higher in children postcardiac surgery than in the other
patients who required CRRT (43% vs 29%; P¼ .051). The
cause of death was multiorgan failure in 46% of patients,
cardiogenic shock in 40% of patients, brain death in 3%450 The Journal of Thoracic and Cardiovascular Surgof patients, and withdrawal of life-sustaining care due to ir-
reversibility of the underlying disease in 11.4% of patients.
Table 6 shows the univariate analysis of the risk factors
for mortality in children on CRRT after cardiac surgery.
The factors associated with an increase in the risk of mortal-
ity were age less than 12 months, weight less than 10 kg, the
presence of hypotension before starting CRRT, the state of
clinical severity measured by the PRIMS at the time of start-
ing CRRT, and lower urea and creatinine concentrations at
the time of starting CRRT (Table 6).
The mean age of the patients who died was lower (30
months) than that of the survivors (64 months) (P ¼ .026).
Patients who died had a higher PRISM score (18 vs 14;
P ¼ .007) and PELOD score (21 vs 17; P ¼ .046). The
mortality in children with hypotension before starting
CRRT was significantly higher than in other children on
CRRT after cardiac surgery (51.1% vs 25.8%; P ¼ .03).ery c August 2013
TABLE 3. Comparison between children after cardiac surgery and
other critically ill patients requiring continuous renal replacement
therapy
Cardiac surgery
n ¼ 81
Mean (SD)
Other patients
n ¼ 93
Mean (SD) P
Age (mo) 50 (64) 55 (64) .807
PRISM (%M) 21 (22) 20 (25) .172
PIM (%M) 9 (14) 12 (17) .363
PELOD (%M) 20 (29) 25 (28) .168
No. of organ failures 3.1 (0.7) 2.9 (1.5) .213
Lactate (mmol/L) 3.1 (3.6) 3.1 (3.7) .440
Arterial pH 7.35 (0.1) 7.29 (0.1) .065
MAP (mm Hg) 55 (14) 66 (23) .003
Vasoactive inotropic score 75.6 (141.9) 55.1 (90.1) <.001
Dose of epinephrine
(mg/kg/min)
0.6 (1.5) 0.4 (0.8) .008
Dose of dopamine
(mg/kg/min)
10 (6) 8 (7) .003
Initial creatinine (mg/dL) 1.1 (0.8) 1.9 (1.7) .002
Initial urea (mg/dL) 70 (46) 98 (68) .004
ALT (IU/L) 223 (764) 181 (642) .635
Bilirubin (mg/dL) 2.1 (2.8) 1.6 (1.4) .609
Maximum dose of heparin
(U/kg/h)
17 (11) 13 (10) .042
Total effluent flow rate
(mL/kg/h)
53 (19) 62 (33) .518
Mean filter life (h) 50 (48) 36 (31) .027
Total duration of therapy 271 (357) 148 (188) .025
Patients, n (%) Patients, n (%)
Sex (male) 55 (68%) 50 (54%) .06
Mechanical ventilation 78 (98%) 67 (73%) <.001
Dialysis technique
(hemodiafiltration)
57 (70%) 72 (77%) .290
Vasoactive drugs 77 (95%) 59 (63%) <.001
Initial hypotension 45 (59%) 27 (34%) .001
SD, Standard deviation; PRISM, Pediatric Risk of Mortality; %M, mortality;
PIM, Pediatric Index of Mortality; PELOD, Pediatric Logistic Organ Dysfunction;
MAP, mean arterial pressure; ALT, alanine aminotransferase. Vasoactive-Inotropic
Score (mg/kg/min): dopamine þ dobutamine þ (epinephrine 3 100) þ
(norepinephrine 3 100) þ (isoproterenol 3 100) þ (milrinone 3 15).
TABLE 4. Complications of continuous renal replacement therapy:
Comparison between children with heart disease and other patients
Cardiac
surgery
Other
patients
Pn % n %
Complications of catheterization 5 6.3 8 8.7 .545
Significant hemorrhage 10 12.5 8 8.7 .416
Hypotension on connection to the filter 27 33.8 26 28.3 .437
Hyponatremia (Na<130 mEq/L) 4 9.3 6 15 .426
Hypocalcemia (total Ca<8 mg/dL) 0 0 4 10.3 .071
Hypokalemia (K<3 mEq/L) 3 7 2 4.9 .049
Hypomagnesemia (mg<1.5 mg/dL) 2 5 1 2.9 .892
Hypophosphatemia (P<4 mg/dL in
children aged<6 y and P<3 mg/dL
in children aged>6 y)
20 42.6 19 47.5 .644
Thrombocytopenia 13 27.7 11 23.4 .636
Na, Sodium;Ca, calcium;K, potassium;P, phosphorus. Definitions: Complications of
catheterization: hemorrhagewith a decrease of>2 g/dL in the hemoglobin concentra-
tion or hypotension or the need for transfusion or withdrawal of the catheter from that
site, thrombosis, pneumothorax, and altered limb perfusion. Significant hemorrhage:
a decrease of>2 g/dL in the hemoglobin concentration in the first 24 hours after
bleeding or hypotension and that required packed red cell transfusion. Hypotension
on connection to the filter: During the first 60 minutes after the connection to
CRRT: a decrease in mean arterial pressure>20 mm Hg over baseline or>2 standard
deviations below the normal value for age and that required volume expansion or an
increase in the dose of vasoactive drugs that the patient was receiving. Thrombocyto-
penia: platelets<100,000/mm3.
Santiago et al Perioperative ManagementPatients treated using hemodiafiltration had a lower mor-
tality than those treated using only hemofiltration. There
were no differences in the filtration rate (dialysis þ ultrafil-
tration) between the survivors (35 [22] mL/kg/h) and the pa-
tients who died (36 [21] mL/kg/h), or in the decrease in urea
and creatinine levels. The only factor associated with mor-
tality in the multivariate analysis was hypotension before
starting CRRT (HR, 4.01; 95% CI, 1.2-13.4; P ¼ .024).P
MDISCUSSION
Renal replacement therapy used in children with AKI af-
ter cardiac surgery has varied over time. Initially, the most
widely used technique was peritoneal dialysis, but in recent
decades this has been displaced by venovenous CRRTThe Journal of Thoracic and Ca(except in the neonatal period) because of the greater effi-
cacy and predictability of this latter technique. However,
there is only 1 study19 that has compared the 2 techniques,
and few patients were analyzed in each group (5). In the
study by Fleming and colleagues,19 CRRTachieved a better
fluid and electrolyte balance than peritoneal dialysis, al-
though there was no difference in survival. In our study,
81 (4.9%) of the 1650 patients who underwent open surgery
required CRRT. This figure is similar to the figures reported
by other authors.3-5,20
It is important to define the AKI, hypervolemia, and cri-
teria to start CRRT, which is difficult because the indication
depends not only on the renal function but also on the hyper-
volemia, fluid balance, and failure of other organs.
Although it is not possible to define the precise indications,
the most important fact is that creatinine and urea levels are
not the definitive criteria.
The time of the CRRT initiation also is important. The
time between the clinical indication of CRRTand the begin-
ning of the technique is most important.21 Several studies
have shown that one of the most important prognosis factors
is the positive fluid balance before initiation of CRRT.22,23 It
is important to begin CRRT early if the fluid balance is
positive with increasing doses of diuretics.
In some PICUs, the initiation of CRRT is delayed be-
cause the nephrologist team determines when to start the
technique, normally in the morning. In our PICU, the inten-
sivist determines when to start the technique regardless of
the time of day, and there is little delay before the indicationrdiovascular Surgery c Volume 146, Number 2 451
TABLE 5. Comparison of children requiring continuous renal
replacement therapy after cardiac surgery in relation to age
<1 y
n ¼ 43
Mean (SD)
>1 y
n ¼ 38
Mean (SD) P
PRISM (%M) 21.3 (20.5) 19.9 (23.4) .342
PIM (%M) 9.9 (17.1) 8.9 (9.9) .600
PELOD (%M) 22.6 (27.6) 27.2 (28.5) .470
No. of organ failures 3.1 (0.7) 3.1 (0.7) .747
Lactate (mmol/L) 2.5 (2.4) 3.7 (4.6) .388
Arterial pH 7.34 (0.07) 7.37 (0.08) .532
MAP (mm Hg) 52.3 (13.7) 58.7 (14.7) .008
Vasoactive-inotropic score 88.8 (189.4) 61 (53.1) .620
Dose of epinephrine
(mg/kg/min)
0.7 (1.9) 0.5 (0.6) .563
Dose of dopamine (mg/kg/min) 11.7 (6.8) 9 (4.1) .086
Initial creatinine (mg/dL) 0.7 (0.5) 1.5 (0.8) <.001
Initial urea (mg/dL) 53 (30.3) 87.6 (52.9) .000
ALT (IU/L) 52 (100) 408 (1093) .276
Bilirubin (mg/dL) 1.2 (1.3) 3.1 (3.7) .037
Maximum dose of heparin
(U/kg/h)
16.3 (12.5) 18.1 (10) .274
Total effluent flow rate
(mL/kg/h)
61.2 (20.2) 48.3 (16.9) .025
Mean filter life (h) 38.7 (43.8) 63.1 (49.1) .001
Total duration of therapy (h) 228 (348) 319 (365) .003
Patients, n (%) Patients, n (%)
Sex (male) 12 (27.9%) 24 (63.2%) .390
Mechanical ventilation 43 (100%) 14 (36.8%) .123
Dialysis technique
(hemodiafiltration)
24 (55.8%) 33 (86.8%) .002
Vasoactive drugs 40 (93%) 37 (97.4%) .368
Mortality 22 (51.3%) 13 (34.2%) .177
Initial hypotension 19 (48.7%) 26 (70.3%) .056
Complications of
catheterization
4 (9.3%) 1 (2.7%) .224
Significant hemorrhage 6 (14%) 4 (10.8%) .672
Hypotension on connection
to the filter
14 (32.6%) 13 (35.1%) .808
Hyponatremia
(Na<130 mEq/L)
3 (17.6%) 1 (3.8%) .128
Hypocalcemia (total Ca<8
mg/dL)
0 (0%) 0 (0%) —
Hypokalemia (K<3 mEq/L) 1 (5.9%) 0 (0%) .945
Hypomagnesemia
(mg<1.5 mg/dL)
1 (6.3%) 1 (4.2%) .686
Hypophosphatemia
(P<4 mg/dL in children
aged<6 y and P<3 mg/dL
in children aged>6 y)
14 (70%) 6 (22.2%) .001
Thrombocytopenia
(<100.000/mm3)
14 (63.6%) 12 (48%) .282
SD, Standard deviation; PRISM, Pediatric Risk of Mortality; %M, mortality; PIM,
Pediatric Index of Mortality; PELOD, Pediatric Logistic Organ Dysfunction; MAP,
mean arterial pressure; ALT, alanine aminotransferase; Na, sodium; K, potassium;
P, phosphorus. Vasoactive-inotropic score (mg/kg/min): dopamine þ dobutamine þ
(epinephrine 3 100) þ (norepinephrine 3 100) þ (isoproterenol 3 100) þ
(milrinone 3 15).
TABLE 6. Univariate Cox regression analysis of factors associated
with mortality in children on continuous renal replacement therapy
after cardiac surgery
HR* 95% CI P
Age 12 mo 1.99 (1-3.98) .050
Weight<10 kg 2.31 (1.13-4.74) .022
PRISM 21 2.18 (0.99-4.80) .052
PIM 1.40 (0.73-2.72) .314
PIM%M 1.00 (0.98-1.03) .747
PELOD 22 1.73 (0.64-4.70) .278
No. of organ failures 0.89 (0.54-1.48) .651
Lactate 0.99 (0.9-1.09) .832
Initial arterial pH 0.37 (0-183) .817
Mean arterial pressure 2.04 (0.99-4.18) .052
Hypotension 2.25 (1-5.08) .050
Vasoactive drugs 0.57 (0.13-2.4) .441
Dose of adrenaline 1.49 (1.19-1.88) .001
Dose of dopamine 1.05 (0.98-1.12) .160
Mechanical ventilation 20.90 (0-38) .680
Initial creatinine 0.46 (0.25-0.85) .013
Initial urea 0.99 (0.98-1) .040
Creatinine at the end of CRRT 0.75 (0.3-1.91) .552
Urea at the end of CRRT 1.01 (0.99-1.02) .311
Alanine aminotransferase 1.00 (1-1) .894
Bilirubin (mg/dL) 0.94 (0.7-1.24) .646
Filtration technique (hemofiltration) 8.36 (3.25-21.5) <.001
Ultrafiltration rate 0.99 (0.98-1.01) .526
Total effluent flow 1.02 (1-1.04) .073
Filter surface<0.15 m2 1.54 (0.72-3.3) .262
Initial period of the study 1996-2002 1.32 (0.61-2.86) .484
HR, Hazard ratio; CI, confidence interval; PRISM, Pediatric Risk of Mortality; PIM,
Pediatric Index of Mortality; %M, mortality; PELOD, Pediatric Logistic Organ
Dysfunction; CRRT, continuous renal replacement therapy. *HR>1 indicates higher
mortality.
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Mand initiation of the technique; thus, many of our patients
had normal levels of creatinine and urea levels at the begin-
ning of the CRRT.
A large proportion of children who required CRRT after
cardiac surgery were aged less than 12 months, and 26%
weighed less than 5 kg. This makes it more difficult to per-
form CRRT because of the complexity of canalization, the
smaller caliber of the vascular access and catheters used,
and the greater hemodynamic repercussion of the technique
because the extracorporeal circuit represents a larger per-
centage of body volume.
Although more patients in the period after cardiac sur-
gery had hypotension, and a larger percentage required ino-
tropic drugs or mechanical ventilation at the time of starting
CRRT, the indices of severity (PRISM, PIM, and PELOD)
were not significantly higher.
Low cardiac output is the main factor related to AKI after
cardiac surgery. In those undergoing heart transplantation,
the toxicity of immunosuppression drugs also contributes
to AKI, which could explain the high frequency of CRRT
in these patients.ery c August 2013
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CRRT was lower in patients undergoing cardiac surgery,
probably because renal replacement therapy was started
earlier in this group of patients if hypervolemia refractory
to diuretics was detected.
CRRTwas continued for approximately twice as long in
children after cardiac surgery than in other critically ill chil-
dren, likely reflecting a slower recovery of the underlying
disease in patients with low cardiac output syndrome. In
the logistic regression study, cardiac surgery significantly
increased the risk of prolonged CRRT.
Mean filter life was slightly longer in the patients on
CRRT after cardiac surgery, although the heparin doses
were slightly higher in these patients, which could explain
the moderate increase in filter life.
There was a high incidence of CRRT-related complica-
tions, similar to the incidence reported by other authors.2,23,24
However, the majority of complications were mild (eg,
electrolyte imbalance) and corrected during treatment. We
did not find a higher percentage of complications in
children after cardiac surgery than in other critically ill
children, except for a slightly higher frequency of
hypokalemia.
Mortality in children after cardiac surgery (43%) was
higher than in other critically ill children (29%). Few
studies have analyzed the mortality of patients requiring
CRRT after cardiac surgery. The onset of dialysis-
dependent acute renal failure increased mortality. In adults,
mortality in this group is 30% to 70%.20,25,26 Factors
associated with a higher mortality in adults requiring
CRRT after cardiac surgery are poor left ventricular
function, diabetes mellitus, peripheral vascular disease, the
need for emergency surgery, and preoperative serum
creatinine levels.20-23
Only 1 study2 has performed a retrospective analysis of
the clinical course of 25 children on CRRT after cardiac
surgery. In the study by Jander and colleagues,2 32% of
the patients died during CRRT, although the final mortality
was of 76%.
Few studies have analyzed prognostic factors in critically
ill children in whom renal failure develops or who require
CRRT. Clinical severity, hemodynamic disturbances, num-
ber of organ failures, and a positive fluid balance before
starting treatment are the main factors that determine the
prognosis.22,23,27,28
In our study of children after cardiac surgery, those aged
more than 1 year and weighing more than 10 kg had a lower
mortality than younger or smaller patients, as has been re-
ported in other studies in children.23,29 However, in the
multivariate logistic regression, age was not a factor that
significantly increased the risk of mortality.
Patients treated with only hemofiltration (ie, those who
presented hypervolemia with no marked increase in the
urea or creatinine) presented a higher mortality thanThe Journal of Thoracic and Capatients treated with hemodiafiltration, in whom the urea
and creatinine levels were higher. This finding also was
observed by Jander and colleagues.2 The mode of CRRT
probably did not affect the outcome; however, it will be nec-
essary to perform prospective studies in children to analyze
this aspect. On the other hand, although there is no evidence
for the superiority of hemofiltration or dialysis, the use
of both convective and diffusive clearance enables a low
filtration fraction to be maintained.
Some studies found that the use of high volumes of ultra-
filtration improved the prognosis in critically ill adult pa-
tients undergoing renal replacement therapy,30 although
more recent studies have not confirmed these findings.31
In our study, we used high mean filtration rates and did
not observe differences in the ultrafiltration rate between
patients who died and patients who survived.
In the multivariate analysis, the only risk factor that was
related to a higher risk of mortality was a previous hemody-
namic disturbance, evidenced as hypotension (HR, 4.01;
95%CI, 1.2-13.4; P¼ .024), a finding also reported in other
studies in children.8,18 This supports the idea that the
outcome in children requiring dialysis is not directly
related to the CRRT but rather to the previous state of
clinical severity and, particularly in patients after cardiac
surgery, to hemodynamic disturbances.
The PRISM, PIM, and PELOD scores were significantly
higher in the patients who died than in the survivors, agree-
ing with the results of other studies.11,32 However, the 3
scales underestimated the risk of mortality. Other studies
also have indicated that the PRISM has a poor ability to
predict mortality in patients with acute renal failure33,34
and patients on intermittent dialysis.CONCLUSIONS
Although only a small percentage of children undergoing
cardiac surgery require CRRT, there is an elevated mortality
in these patients, higher than in other critically ill children
requiring CRRT. Hypotension at the time of starting the
treatment is the only factor associated with a higher
mortality.
The authors thank the nurses and doctors of the Pediatric Inten-
sive Care Department of the GregorioMara~nonGeneral University
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